Jazz Pharmaceuticals Plc Stock Buy Hold or Sell Recommendation
| JAZZ Stock | USD 124.39 2.35 1.93% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Jazz Pharmaceuticals PLC is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Jazz Pharmaceuticals PLC given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Jazz Pharmaceuticals PLC, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Jazz Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Jazz and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Jazz Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Jazz |
Execute Jazz Pharmaceuticals Buy or Sell Advice
The Jazz recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Jazz Pharmaceuticals PLC. Macroaxis does not own or have any residual interests in Jazz Pharmaceuticals PLC or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Jazz Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Jazz Pharmaceuticals Trading Alerts and Improvement Suggestions
| Jazz Pharmaceuticals is unlikely to experience financial distress in the next 2 years | |
| Jazz Pharmaceuticals has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from aol.com: NBA reschedules Lakers, Clippers games postponed to avoid L.A. wildfires |
Jazz Pharmaceuticals Returns Distribution Density
The distribution of Jazz Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Jazz Pharmaceuticals' future price movements. The chart of the probability distribution of Jazz Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Jazz Pharmaceuticals PLC price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Jazz Pharmaceuticals returns is essential to provide solid investment advice for Jazz Pharmaceuticals.
| Mean Return | 0.16 | Value At Risk | -2.65 | Potential Upside | 2.84 | Standard Deviation | 1.77 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Jazz Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Jazz Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Jazz Pharmaceuticals, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Jazz Pharmaceuticals PLC back and forth among themselves.
| Shares | Camber Capital Management Llc | 2024-09-30 | 1.1 M | Franklin Resources Inc | 2024-09-30 | 1.1 M | Geode Capital Management, Llc | 2024-09-30 | 1.1 M | Citadel Advisors Llc | 2024-09-30 | 1.1 M | Renaissance Technologies Corp | 2024-09-30 | 1 M | Swedbank Ab | 2024-09-30 | 1 M | Vestal Point Capital Lp | 2024-09-30 | 900 K | Fmr Inc | 2024-09-30 | 835.9 K | Thompson, Siegel & Walmsley Llc | 2024-09-30 | 781.2 K | Vanguard Group Inc | 2024-09-30 | 6.1 M | Blackrock Inc | 2024-09-30 | 5.9 M |
Jazz Pharmaceuticals Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (30.5M) | (48.9M) | (49.6M) | (13.4M) | (12.1M) | (12.7M) | |
| Change In Cash | 420.4M | (466.3M) | 290.0M | 624.8M | 718.6M | 754.5M | |
| Free Cash Flow | 520.4M | 733.0M | 773.8M | 1.1B | 1.2B | 1.3B | |
| Depreciation | 278.3M | 552.5M | 629.5M | 638.7M | 734.5M | 771.2M | |
| Other Non Cash Items | 484.2M | 345.4M | 926.9M | 276.3M | 317.7M | 170.7M | |
| Capital Expenditures | 379.3M | 45.5M | 498.2M | 24.0M | 27.6M | 26.2M | |
| Net Income | 238.6M | (329.7M) | (224.1M) | 414.8M | 477.1M | 500.9M | |
| End Period Cash Flow | 1.1B | 591.4M | 881.5M | 1.5B | 1.7B | 1.8B | |
| Investments | (642.7M) | 1.1B | (1.0M) | (589.2M) | (530.3M) | (503.8M) | |
| Net Borrowings | (33.4M) | 591.8M | 3.9B | (582.0M) | (669.3M) | (635.9M) | |
| Change To Netincome | (9.3M) | 155.2M | 603.6M | 139.1M | 160.0M | 90.9M |
Jazz Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Jazz Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Jazz Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Jazz stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.15 | |
β | Beta against Dow Jones | 0.04 | |
σ | Overall volatility | 1.75 | |
Ir | Information ratio | 0.04 |
Jazz Pharmaceuticals Volatility Alert
Jazz Pharmaceuticals PLC has relatively low volatility with skewness of 0.89 and kurtosis of 2.44. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Jazz Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Jazz Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Jazz Pharmaceuticals Fundamentals Vs Peers
Comparing Jazz Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Jazz Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Jazz Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Jazz Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Jazz Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Jazz Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Jazz Pharmaceuticals to competition |
| Fundamentals | Jazz Pharmaceuticals | Peer Average |
| Return On Equity | 0.12 | -0.31 |
| Return On Asset | 0.0462 | -0.14 |
| Profit Margin | 0.12 % | (1.27) % |
| Operating Margin | 0.25 % | (5.51) % |
| Current Valuation | 11.1 B | 16.62 B |
| Shares Outstanding | 60.45 M | 571.82 M |
| Shares Owned By Insiders | 2.93 % | 10.09 % |
| Shares Owned By Institutions | 98.79 % | 39.21 % |
| Number Of Shares Shorted | 4.26 M | 4.71 M |
| Price To Earning | 35.18 X | 28.72 X |
| Price To Book | 1.80 X | 9.51 X |
| Price To Sales | 1.87 X | 11.42 X |
| Revenue | 3.83 B | 9.43 B |
| Gross Profit | 3.7 B | 27.38 B |
| EBITDA | 1.23 B | 3.9 B |
| Net Income | 414.83 M | 570.98 M |
| Cash And Equivalents | 899.36 M | 2.7 B |
| Cash Per Share | 14.28 X | 5.01 X |
| Total Debt | 5.79 B | 5.32 B |
| Debt To Equity | 2.12 % | 48.70 % |
| Current Ratio | 3.16 X | 2.16 X |
| Book Value Per Share | 69.01 X | 1.93 K |
| Cash Flow From Operations | 1.09 B | 971.22 M |
| Short Ratio | 7.04 X | 4.00 X |
| Earnings Per Share | 7.07 X | 3.12 X |
| Price To Earnings To Growth | 0.85 X | 4.89 X |
| Target Price | 181.05 | |
| Number Of Employees | 2.8 K | 18.84 K |
| Beta | 0.57 | -0.15 |
| Market Capitalization | 7.47 B | 19.03 B |
| Total Asset | 11.39 B | 29.47 B |
| Retained Earnings | 878.66 M | 9.33 B |
| Working Capital | 1.9 B | 1.48 B |
Note: Disposition of 1500 shares by Bruce Cozadd of Jazz Pharmaceuticals at 123.43 subject to Rule 16b-3 [view details]
Jazz Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Jazz . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Jazz Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Jazz Pharmaceuticals PLC? Buying financial instruments such as Jazz Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Jazz Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Discretionary ETFs Thematic Idea Now
Consumer Discretionary ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Discretionary ETFs theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Discretionary ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Jazz Stock Analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.